ACTIVE

TRISPORT PHARMA

Financial year 2025 · Closed on 31/12/2025

Net result
21,7 k €
+272,6 %over 1 year
Gross margin
17,5 k €
+368,0 %over 1 year
Equity
11,5 k €
+212,8 %over 1 year

Identity

Source · BCE/KBO

TRISPORT PHARMA is a Private company with limited liability incorporated in 1988. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Beernem.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0433.713.130
Incorporation
18/03/1988
Legal form
Private company with limited liability
Registered office
Gevaerts-Noord 4
8730 Beernem · FlandreSee on map
Contributed capital
48 339,24 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin17,5 k €-6,5 k €-10,2 k €-21,8 k €21,5 k €
EBITDA16,7 k €-7,2 k €-11,2 k €-23 k €18,5 k €
Operating result16,7 k €-7,2 k €-11,2 k €-23 k €18,5 k €
Net result21,7 k €-12,6 k €-12,1 k €-22,3 k €17 k €
Balance sheet
Equity11,5 k €-10,2 k €2,4 k €14,4 k €36,7 k €
Total assets86,3 k €81,6 k €88,5 k €94,8 k €119,8 k €
Cash13,3 k €26,2 k €8,2 k €13,1 k €27,2 k €
Debts74,8 k €91,8 k €86,1 k €80,4 k €83 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 11 ended

Active mandates

Kurt Vancoppenolle

Director · since 15 février 2013

Active
Michèle Boutlegier

Director · since 15 février 2013

Active

Ended mandates

Bloemeghem

Manager · since 09 mai 2014 · 0838.474.037

Represented by Michèle Boutlegier

Ended
Kurt Vancoppenolle

Manager · since 09 mai 2014

Ended
Michèle Boutlegier

Manager · since 09 mai 2014

Ended
Marc Lamberts

Manager · since 15 février 2005

Ended

Other companies at this address

Gevaerts-Noord 4 8730 Beernem
CompanyCBE no.
Bloemeghem● Active
0838.474.037

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date26/08/202623/07/202530/08/202425/09/202331/08/202231/08/2021
General meeting30/06/202616/05/202530/06/202430/08/202310/08/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/06/202626/08/2026DutchPDF
Micro model31/12/202416/05/202523/07/2025DutchPDF
Micro model31/12/202330/06/202430/08/2024DutchPDF
Micro model31/12/202230/08/202325/09/2023DutchPDF
Micro model31/12/202110/08/202231/08/2022DutchPDF
Micro model31/12/202030/06/202131/08/2021DutchPDF
Micro model31/12/201910/08/202011/08/2020DutchPDF
Micro model31/12/201828/06/201930/08/2019DutchPDF
Micro model31/12/201730/06/201830/08/2018DutchPDF
Micro model31/12/201601/06/201721/06/2017DutchPDF
Abridged model31/12/201520/05/201624/06/2016DutchPDF
Abridged model31/12/201430/06/201506/07/2015DutchPDF
Abridged model31/12/201316/05/201414/07/2014DutchPDF
Abridged model31/12/201217/05/201328/08/2013DutchPDF
Abridged model31/12/201118/05/201220/07/2012DutchPDF
Abridged model31/12/201020/05/201122/08/2011DutchPDF
Abridged model31/12/200921/05/201025/08/2010DutchPDF
Abridged model31/12/200815/05/200903/06/2009DutchPDF
Abridged model31/12/200716/05/200807/07/2008DutchPDF
Abridged model31/12/200618/05/200715/06/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 11 ended

Active mandates

Kurt Vancoppenolle

Director · since 15 février 2013

Active
Michèle Boutlegier

Director · since 15 février 2013

Active

Ended mandates

Bloemeghem

Manager · since 09 mai 2014 · 0838.474.037

Represented by Michèle Boutlegier

Ended
Kurt Vancoppenolle

Manager · since 09 mai 2014

Ended
Michèle Boutlegier

Manager · since 09 mai 2014

Ended
Marc Lamberts

Manager · since 15 février 2005

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office07/04/2017
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates19/05/2014
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/04/2013
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other04/12/2009
    BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates09/09/2009
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/04/2008
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office05/10/2006
    ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates02/03/2005
    MAATSCHAPPELIJKE ZETEL - BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202521,7 k €↑
  2. 2024
    Annual accounts 2024-12,6 k €↓
  3. 2023
    Annual accounts 2023-12,1 k €↑
  4. 2022
    Annual accounts 2022-22,3 k €↓
  5. 2021
    Annual accounts 202117 k €↑
  6. 2020
    Annual accounts 2020-4,2 k €↑
  7. 2019
    Annual accounts 2019-29,9 k €↓
  8. 2018
    Annual accounts 20183,2 k €↑
  9. 2017
    Annual accounts 2017-833,4 €↓
  10. 2016
    Annual accounts 2016-239,6 €↑
  11. 2015
    Annual accounts 2015-862,1 €↓
  12. 2014
    Annual accounts 20149,1 k €↑
  13. 2013
    Annual accounts 2013-13,3 k €↓
  14. 2012
    Annual accounts 20121,2 k €↓
  15. 2011
    Annual accounts 20118,7 k €↑
  16. 2010
    Annual accounts 2010-1,8 k €↓
  17. 2009
    Annual accounts 200910,3 k €↑
  18. 2009
    Name changeTrisport-Pharma
  19. 2008
    Annual accounts 2008-16,2 k €↓
  20. 2007
    Annual accounts 200718,5 k €↑
  21. 2006
    Annual accounts 200615,5 k €
  22. 2006
    Name changeTRIMEDICO
  23. 18/03/1988
    IncorporationPrivate company with limited liability